KR20020040532A - Antioxidative drink excellent in inhibiting the side effects according to anticancer therapy and the method of manufacturing the same - Google Patents

Antioxidative drink excellent in inhibiting the side effects according to anticancer therapy and the method of manufacturing the same Download PDF

Info

Publication number
KR20020040532A
KR20020040532A KR1020010024720A KR20010024720A KR20020040532A KR 20020040532 A KR20020040532 A KR 20020040532A KR 1020010024720 A KR1020010024720 A KR 1020010024720A KR 20010024720 A KR20010024720 A KR 20010024720A KR 20020040532 A KR20020040532 A KR 20020040532A
Authority
KR
South Korea
Prior art keywords
antioxidant
red ginseng
saponin
weight
low molecular
Prior art date
Application number
KR1020010024720A
Other languages
Korean (ko)
Other versions
KR100355012B1 (en
Inventor
김장수
강명화
정혜경
송은승
민관식
Original Assignee
카부시키가이샤토오요오핫코오
김장수
(주)수진바이오텍
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 카부시키가이샤토오요오핫코오, 김장수, (주)수진바이오텍 filed Critical 카부시키가이샤토오요오핫코오
Priority to KR1020010024720A priority Critical patent/KR100355012B1/en
Priority to JP2002132067A priority patent/JP2002348245A/en
Publication of KR20020040532A publication Critical patent/KR20020040532A/en
Application granted granted Critical
Publication of KR100355012B1 publication Critical patent/KR100355012B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/38Other non-alcoholic beverages
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52Adding ingredients
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/308Foods, ingredients or supplements having a functional effect on health having an effect on cancer prevention
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00Food ingredients
    • A23V2250/20Natural extracts
    • A23V2250/21Plant extracts
    • A23V2250/2124Ginseng

Landscapes

  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Non-Alcoholic Beverages (AREA)

Abstract

PURPOSE: A process of preparing an antioxidant drink having excellent antioxidant action by mixing low molecular weight red ginseng saponin and glutamate and an auxiliary component is provided. Whereby, the drink has an excellent effect on suppressing side effects caused by anticancer treatment and preventing various diseased caused by free radials. CONSTITUTION: This antioxidant drink is prepared by the subsequent processes: enzyme-treating saponin of red ginseng to make low molecular weight; mixing 1 to 15% by weight of saponin, 1 to 5% by weight of glumate having an active oxygen suppressing effect, an auxiliary component for improving antioxidant functionality and an additive and then absolutely dissolving in purified water; and filtering the mixed solution.

Description

항암요법에 따른 부작용 억제 효과를 갖는 항산화 음료 및 그 제조방법{Antioxidative drink excellent in inhibiting the side effects according to anticancer therapy and the method of manufacturing the same}Antioxidant drink excellent in inhibiting the side effects according to anticancer therapy and the method of manufacturing the same}

본 발명은 항암요법에 따른 부작용 억제 효과를 갖는 항산화 음료 및 그 제조 방법에 관한 것으로서 보다 상세하게는 항산화 활성을 갖는 저분자화된 홍삼 사포닌과 활성산소 억제물질인 글루메이트(Glumate, GMT)를 포함하여 제조함으로써 항산화 활성이 우수한 항암요법에 따른 부작용 억제 효과를 갖는 항산화 음료 및 그 제조 방법에 관한 것이다.The present invention relates to an antioxidant drink having a side effect inhibitory effect according to anticancer therapy and a method for preparing the same, and more particularly, including low molecular weight red ginseng saponin having antioxidant activity and glutamate (Glumate, GMT) which is an active oxygen inhibitor. The present invention relates to an antioxidant beverage having a side effect inhibiting effect according to an anticancer therapy having excellent antioxidant activity, and a method for producing the same.

자유 라디칼(Free radical)은 하나 이상의 짝을 이루지 못한 전자를 가지고 있는 분자로서 다른 분자로부터 전자를 빼앗아 안정화하려는 특성을 지니고 있다. 또한자유 라디칼은 수명이 수천 분의 일초 정도로 짧아 매우 불안정하고 공격적이며 강한 산화력을 가지고 있다. 자유 라디칼의 대부분은 활성 산소종(Reactive Oxygen Species)으로, 그 종류로는 히드록실 라디칼(hydroxyl radical), 슈퍼옥사이드 라디칼(superoxide radical), 일중항 산소(singlet oxygen) 및 과산화수소(H2O2)와 지질과산화에 따라 발생하는 알콕실 라디칼(alkoxyl radical) 등이 있다.Free radicals are molecules that have one or more unpaired electrons and have the property of stabilizing electrons from other molecules. Free radicals are also very unstable, aggressive, and strong in oxidative power, with lifespans as short as thousands of seconds. Most of the free radicals are reactive oxygen species, which include hydroxyl radicals, superoxide radicals, singlet oxygen, and hydrogen peroxide (H 2 O 2 ). And alkoxyl radicals generated by lipid peroxidation.

체내에서 이러한 활성 산소종을 발생시키는 통상의 인자로서, 스트레스, 알콜, 과산화물, 약물 등이 공지되어 있다.As a common factor for generating such reactive oxygen species in the body, stress, alcohols, peroxides, drugs and the like are known.

한편, 현재 전 세계적으로 수천만 명이 넘는 암환자들이 있으며 이들에게 적용되는 항암 요법이 모두 심각한 부작용을 나타내며 그 부작용들 또한 공통적으로 자유 라디칼에 기인하는 것으로 알려져 있다.On the other hand, there are more than tens of millions of cancer patients all over the world, and all of the anticancer therapies applied to them are known to have serious side effects, which are commonly known to be caused by free radicals.

대표적인 항암 요법과 그 부작용을 살펴보면, 먼저 방사선 요법으로 X선 및 α, β, γ선 등에 의한 방사선 조사에 의한 DNA의 분해, 세포의 사멸, 증식 능력의 소실, 돌연변이, 종양세포의 형질변이 등 많은 화학적 변화를 가져온다. 또한, 외과요법으로 수술요법을 시행시에 전신 또는 국소마취제, 지혈제, 혈액 응고 방지제 및 진통제의 병용투여에 따른 약물에 의한 활성 산소의 발생(OH·, NO2등)과 대사 과정의 일시적 불균형 및 출혈에 따른 일시적 빈혈 등 산화적 스트레스(Oxidative stress)에 의한 체내의 활성 산소 대량 발생으로 피로감, 백혈구 수치의 저하, 면역력 저하, 혈소판 감소 등의 부작용을 가져올 수 있다. 화학 요법으로 대표적인 제암제로서 아드리아마이신(adriamycin), 블레오마이신(bleomycin),마이토마이신(mitomycin), 시스플라틴(cisplatin) 등이 있으며, 이들의 장기 투여시 DNA의 합성과 세포분열의 억제 및 세포막 손상 등 DNA 손상으로 인한 가역적 또는 비가역적 부작용을 유발한다. 상술한 바와 같이 대부분의 항암 요법은 모두 심각한 부작용을 나타내며 그 부작용의 작용 기전에서 공통적으로 자유 라디칼이 관여되어 있는 것으로 알려져 있다.Representative anti-cancer therapies and their side effects, first of all, radiation therapy, such as X-ray and radiation by irradiation with α, β, γ-rays, DNA degradation, cell death, loss of proliferative capacity, mutation, mutation of tumor cells, etc. Brings chemical changes. In addition, the generation of free radicals (OH, NO 2, etc.) and metabolic processes due to the combination of general or local anesthetics, hemostatic agents, anticoagulants, and analgesics during surgical therapy. Massive generation of free radicals due to oxidative stress such as transient anemia caused by bleeding can cause side effects such as fatigue, lowering white blood cell count, lowering immunity, and reducing platelets. Examples of chemotherapy agents include adriamycin, bleomycin, mitomycin, and cisplatin, which inhibit DNA synthesis, cell division, and cell membrane damage during long-term administration. And can cause reversible or irreversible side effects from DNA damage. As described above, most anti-cancer therapies all have serious side effects, and it is known that free radicals are commonly involved in the mechanism of action of the side effects.

이러한 자유 라디칼에 의한 손상으로부터 스스로를 보호하기 위해 체내에는 일련의 산화 보호 시스템을 갖추고 있다. 이러한 보호 시스템으로 슈퍼옥사이드 디스뮤타즈(superoxide dismutase; SOD), 카탈라제(catalase) 등의 효소와 α-토코페롤(α-Tocopherol, Vitamin E), β-카로틴(β-Carotene), 아스코르빈산(Ascorbic acid, Vitamin C) 및 글루타치온(Glutathione)과 같은 지용성 및 수용성 항산화제 또는 라디칼 소거제들이 포함된다.To protect itself from damage caused by these free radicals, the body is equipped with a series of oxidative protection systems. Such protective systems include enzymes such as superoxide dismutase (SOD) and catalase, and α-tocopherol (vitamin E), β-carotene and ascorbic acid (ascorbic acid). fat-soluble and water-soluble antioxidants or radical scavengers such as acid, Vitamin C) and glutathione.

그러나, 현대인들은 대기환경 오염, 불건전한 식생활, 자외선 노출, 스트레스, 병들의 유해환경에 노출되어 생체내의 라디칼 소거 시스템과의 불균형으로 여러 라디칼들에 의한 산화적 스트레스(oxidative stress)를 충분히 소거하기 어려운 형편이므로 이러한 시스템을 정상적으로 작용시키기 위해 항산화 영양 성분을 충분히 섭취하는 것이 중요하다. 또한, 자체로써 체내에 생성된 활성 산소종을 제거하여 자유 라디칼에 의한 각종 질병 및 부작용을 막을 수 있는 항산화 식품의 개발이 크게 요구되고 있다.However, modern people are exposed to air pollution, unhealthy diet, UV exposure, stress, and harmful environment of illness, and it is difficult to eliminate oxidative stress caused by various radicals due to imbalance with the radical scavenging system in vivo. As a matter of fact, it is important to get enough antioxidant nutrients in order to function properly. In addition, the development of antioxidant foods that can prevent various diseases and side effects caused by free radicals by removing the active oxygen species generated in the body by itself.

한편 인삼은 예로부터 대표적인 자양강장제로 널리 사용되어 온 식물로서, 일반적으로 재배하여 채취한 그대로의 수삼, 수삼을 상온에서 건조시킨 백삼 또는 수삼을98∼100℃에서 가열 처리하여 제조되는 홍삼의 형태로 사용되고 있다. 인삼의 성분과 약효에 대한 많은 연구결과가 보고되어 있는데, 현재까지 알려진 인삼의 약효로는 노화억제, 항동맥경화 및 고지혈증 개선, 간기능항진, 방사선장애 제거, 면역증강, 항혈전, 뇌기능항진, 항스트레스, 혈당강하, 혈압강하 또는 항암효과 등이 있다. 특히 홍삼의 사포닌 성분인 홍삼 토탈 사포닌(total saponine)은 자유 라디칼에 의한 손상이나 지질과산화를 감소시키며 생체계에서 산소에 의해 일어나는 손상을 차단하는 항산화 활성을 갖는 것으로 알려져 있으나 그 효능에 관한 직접적인 연구는 아직까지 미비한 상태이다.On the other hand, ginseng is a plant that has been widely used as a representative nourishing tonic since ancient times, and is generally in the form of red ginseng prepared by heat-treating white ginseng or ginseng dried at room temperature, as it is grown and harvested at room temperature. It is used. Many researches on the components and efficacy of ginseng have been reported.The known effects of ginseng are anti-aging, anti-arteriosclerosis and hyperlipidemia, liver function enhancement, radiation disorder removal, immune enhancement, antithrombosis, brain hyperactivity. , Antistress, lowering blood sugar, lowering blood pressure or anticancer effect. In particular, red ginseng saponins, total saponins, are known to have antioxidant activity that reduces damage caused by free radicals or lipid peroxidation and blocks oxygen-induced damage in the biological system. It is still incomplete.

이에 본 발명은 항산화 활성을 갖는 저분자화된 홍삼 사포닌과 활성산소 억제물질인 글루메이트를 포함하여 제조된 항산화 활성이 우수한 항암요법에 따른 부작용 억제 효과를 갖는 항산화 음료를 제공하는데 그 목적이 있다.Accordingly, an object of the present invention is to provide an antioxidant beverage having a low side effect according to an anticancer therapy having excellent antioxidant activity, including low molecular weight red ginseng saponin and an active oxygen inhibitor glutmate having antioxidant activity.

본 발명의 다른 목적은 저분자화된 홍삼 사포닌, 글루메이트, 항산화 기능성을 향상시키는 보조성분 및 향이나 맛을 가미하는 보조제를 일정한 조성비로 배합하여 상기의 항산화 음료를 제조하는 방법을 제공함에 있다.Another object of the present invention is to provide a method for producing the antioxidant drink by combining a low molecular weight red ginseng saponin, glutate, an auxiliary component to improve antioxidant functionality and an adjuvant to add flavor or taste.

본 발명의 또 다른 목적은 본 발명에 따른 항산화 음료를 지속적으로 음용함으로써 전체적인 면역력의 증강으로 자유 라디칼로부터 기인하는 여러 질병과 부작용을 방지하고 특히, 자유 라디칼이 주요 원인인 항암요법 부작용을 억제할 수 있는 항산화 음료를 제공하는데 있다.Another object of the present invention is to continuously drink the antioxidant drink according to the present invention to prevent various diseases and side effects resulting from free radicals by strengthening the overall immunity, and in particular, to suppress the anticancer therapy side effects, which are the main cause of free radicals To provide an antioxidant drink.

도1은 본 발명에 따른 항암요법에 따른 부작용 억제 효과를 갖는 항산화 음료의 자유 라디칼 소거능을 나타낸 그래프이다.1 is a graph showing the free radical scavenging ability of the antioxidant beverage having the side effect inhibitory effect according to the anticancer therapy according to the present invention.

도2는 본 발명에 따른 항산화 음료의 항산화능에 있어서 글루메이트(GMT)의 역할을 나타낸 그래프이다.Figure 2 is a graph showing the role of glutmate (GMT) in the antioxidant capacity of the antioxidant beverage according to the present invention.

상기 목적을 달성하기 위한 본 발명에 따른 항암요법에 따른 부작용 억제 효과를 갖는 항산화 음료는 항산화 활성을 갖는 저분자화된 홍삼 사포닌과 활성산소 억제 효과를 갖는 글루메이트를 포함하는 것을 특징으로 한다.Antioxidant beverage having a side effect inhibitory effect according to the anticancer therapy according to the present invention for achieving the above object is characterized in that it comprises a low molecular weight red ginseng saponin having antioxidant activity and a glutate having an active oxygen inhibitory effect.

상기 홍삼 사포닌은 1 내지 15 중량%, 글루메이트는 1 내지 6 중량%를 함유하는 것을 특징으로 한다.The red ginseng saponin is 1 to 15% by weight, glutamate is characterized in that it contains 1 to 6% by weight.

본 발명에 따른 항암요법에 따른 부작용 억제 효과를 갖는 항산화 음료의 제조방법은 항산화 활성을 갖는 홍삼 사포닌을 효소 처리하여 저분자화하는 단계, 상기 저분자화된 홍삼 사포닌 1 내지 15 중량%에 글루메이트 1 내지 6 중량%, 항산화 기능성을 향상시키는 보조성분 및 향이나 맛을 가미하는 보조제를 혼합하여 정제수에 완전 용해시키는 단계 및 상기 혼합용액을 살균 밀봉하여 방냉하고 반복 여과 처리하는 단계를 포함하는 것을 특징으로 한다.The method for preparing an antioxidant beverage having the side effect inhibitory effect according to the anticancer therapy according to the present invention comprises the steps of low molecular weight by enzyme treatment of red ginseng saponin having antioxidant activity, 1 to 15% by weight of the low molecular weighted red ginseng saponin 6 wt%, by mixing the auxiliary component to improve the antioxidant function and the additive to add aroma or taste to completely dissolved in purified water and the step of sterilizing and sealing the mixed solution to cool and repeat filtration.

인삼 특유의 약리활성 사포닌인 진세노사이드 유도체들은 다마란계의 트리테르페노이드인 프로토파낙사다이올과 프로토파낙사트라이올의 알코올성 수산기에 글루코오스, 람노스, 자일로스 또는 아라비노스와 같은 당류가 결합한 화합물들로서 그 분자량이 매우 커서 체내 흡수가 용이하지 못하다. 따라서 본 발명에서는 이러한 고분자 사포닌의 체내 흡수를 증가시킬 수 있도록 사포닌을 효소처리에 의해 저분자화시켜 사용하였다. 이 때 효소는 Deerland Cellulase 4000을 사용하며 홍삼 추출물에 0.01% 내지 0.1 중량%를 가하여 홍삼 사포닌을 저분자화하여 체내 흡수를 용이하게 함으로써 항산화 활성을 높이는 역할을 한다.Ginsenoside derivatives, ginseng's unique pharmacologically active saponins, contain sugars such as glucose, rhamnose, xylose or arabinose in the alcoholic hydroxyl groups of the protoparnasadiol and the protoparnasatriol, which are triterpenoids of the dimaran series. As the combined compounds, their molecular weight is so large that absorption into the body is not easy. Therefore, in the present invention, saponins were used in a low molecular weight by enzymatic treatment so as to increase the absorption of the polymer saponins in the body. At this time, the enzyme uses Deerland Cellulase 4000 and adds 0.01% to 0.1% by weight to red ginseng extract to lower the red ginseng saponin to facilitate the absorption in the body, thereby enhancing antioxidant activity.

본 발명에 따른 항암요법에 따른 부작용 억제 효과를 갖는 항산화 음료의 제조 방법에서 사용한 글루메이트는 미당(米糖)과 대두를 알칼리 발효법으로 추출한 것으로 유해 산소 저해제(superoxide dismutase, SOD)작용, 혈압 억제 작용, 항산화 효소 SOD1의 작용에 의하여 생산된 과산화수소를 물과 산소로 분해하는 카탈라제 작용 및 항스트레스 작용도 있는 것으로 알려져 있으며 특히, 활성 산소 및 자유 라디칼인 OH·, H2O2,1O2등의 소거작용에 탁월한 효과가 있는 것으로 알려져 있다. 본 발명에서는 항산화 활성을 증가시키기 위해 일본 동양발효(주)에서 발명한 '미배아, 대두발효 추출물'인 글루메이트 5배 농축액인 GMT-SOD가 사용될 수 있으며 이는 곡류, 종자류 중에 피틴(Phytin)함량이 가장 많은 것을 원료로 호알칼리성 미생물에 의해 발효시켜 제조된 것이다.Glumate used in the preparation method of antioxidant drink having the side effect suppression effect according to the anticancer therapy according to the present invention is extracted from microsaccharides and soybeans by alkaline fermentation, harmful oxygen inhibitor (superoxide dismutase (SOD) action, blood pressure inhibitory effect In addition, catalase and antistress are known to decompose hydrogen peroxide produced by the action of the antioxidant enzyme SOD1 into water and oxygen. In particular, active oxygen and free radicals such as OH ·, H 2 O 2 and 1 O 2 It is known to have an excellent effect on scavenging action. In the present invention, in order to increase the antioxidant activity, GMT-SOD, a glutamate 5-fold concentrate, which is an 'embryonic, soybean fermentation extract' invented by Dongyang Fermentation Co., Ltd., Japan, can be used. Most of them are produced by fermentation by alkalescent microorganisms as raw materials.

상기의 저분자화된 홍삼 사포닌과 글루메이트에 보조성분 및 보조제가 첨가될 수 있다. 이 때 보조성분은 주성분에 부가하여 항산화 기능성을 향상시키는 것으로서 항산화 활성을 갖는 녹차 추출물 및 비타민류로서 비타민 C, 비타민 B1, 비타민 B2등이 사용될 수 있다. 보조제는 향이나 맛을 가미하는 것으로서 예를 들면 허브향, 올리고당, 구연산나트륨 및 C.M.C 등이 사용될 수 있다.Supplementary ingredients and auxiliaries may be added to the low molecular weight red ginseng saponin and glutate. In this case, the auxiliary ingredient may be used as vitamin C, vitamin B 1 , vitamin B 2 , and the like as green tea extract and vitamins having antioxidant activity as an antioxidant function in addition to the main ingredient. Adjuvants add flavors or flavors, for example, herbal flavors, oligosaccharides, sodium citrate, CMC and the like can be used.

이러한 성분을 혼합하여 항산화 음료를 만드는 단계에서 홍삼 사포닌의 양은 전체 음료조성물 중에 1 내지 15 중량%, 글루메이트는 1 내지 6 중량% 범위내에서 사용하는 것이 바람직하다. 이때의 홍삼 사포닌과 글루메이트의 양이 1 중량% 보다 적을 경우는 항산화 활성에 있어서 뚜렷한 효과를 나타내지 못하며 양이 증가할수록 항산화능은 증가한다. 그러나, 홍삼 사포닌의 양이 15 중량%를 초과하는 경우는 홍삼 특유의 쓴맛으로 인하여 음용하기에 적합하지 못하며 글루메이트는 고가의 상품으로 6 중량%이하의 사용에서도 우수한 항산화 활성을 보여준다. 본 발명에 따른 항산화 음료의 바람직한 성분비를 다음의 표1에 나타내었다.The amount of red ginseng saponin in the step of mixing these ingredients to make an antioxidant drink is preferably used in the range of 1 to 15% by weight, glutamate 1 to 6% by weight in the total beverage composition. If the amount of red ginseng saponin and glutate is less than 1% by weight, it does not have a definite effect on the antioxidant activity and the antioxidant activity increases as the amount increases. However, when the amount of red ginseng saponin exceeds 15% by weight, it is not suitable for drinking due to the bitter taste peculiar to red ginseng, and glutmate is an expensive product and shows excellent antioxidant activity even under 6% by weight. Preferred component ratios of the antioxidant beverage according to the present invention are shown in Table 1 below.

표1 항산화 음료의 조성표Table 1 Composition of Antioxidant Beverage

상기의 성분들을 혼합한 용액을 살균, 밀봉하여 방냉한 후 여과하는 단계에서 10μ마이크로 필터를 사용하여 4회 이상 반복하여 여과함으로써 음료 혼합물에 남아 있을 수 있는 불순물을 최대한 제거한다.In the step of sterilizing, sealing and cooling the solution in which the above components are mixed, the filter is repeatedly filtered four or more times using a 10 μ microfilter to remove impurities that may remain in the beverage mixture.

이하에서 본 발명에 의한 음료의 제조 방법과 효과를 실시예를 통하여 더욱 상세히 설명하나, 본 발명의 범위가 하기 실시예만으로 한정되는 것은 아니다.Hereinafter, the method and effect of preparing the beverage according to the present invention will be described in more detail with reference to Examples, but the scope of the present invention is not limited to the following Examples.

실시예 1Example 1

홍삼 500g을 1L의 에탄올에 넣어 70℃에서 초음파장치로 5시간 추출하여 여과시키는 방법을 3회 반복하였다. 2.5L 정도의 홍삼추출물을 감압 농축기로 1.5L까지 감압 농축한 홍삼추출물에 Deerland Cellulase 4000을 0.1% 첨가하고 60℃의 인큐베이터에 넣어 6시간 반응시켰다. 12시간 후 즉시 100℃ 항온수조에서 10분간 열처리하여 효소 불활성화를 행하며 그 직후 3,500 ×g에서 20분간 원심분리하고 상징액을 취하여 저분자화된 홍삼 사포닌을 제조하였다.500 g of red ginseng was added to 1 L of ethanol, and the method of extracting and filtering by ultrasonic apparatus at 70 ° C. for 5 hours was repeated three times. The red ginseng extract of about 2.5L was depressurized to 1.5L with a decompression concentrator, and 0.1% of Deerland Cellulase 4000 was added to the red ginseng extract. After 12 hours, the enzyme was inactivated by heat treatment for 10 minutes in a 100 ° C. constant temperature water bath, followed by centrifugation at 3,500 × g for 20 minutes, and the supernatant was taken to prepare low molecular weight red ginseng saponin.

실시예 2Example 2

정제수에 실시예1에서 제조된 저분자화된 홍삼 사포닌, 글루메이트, 녹차 추출물, 올리고당, 비타민C, 비타민 B1염산염, 비타민 B2, 허브향, 구연산나트륨, C.M.C를 아래 표2의 비율로 혼합하여 80℃에서 완전히 용해시킨 후 95℃에서 30분간 살균한 후 밀봉하여 18시간 방냉하였다.The low molecular weight red ginseng saponin, glutmate, green tea extract, oligosaccharide, vitamin C, vitamin B 1 hydrochloride, vitamin B 2 , herbal flavor, sodium citrate, and CMC prepared in Example 1 were mixed in the ratio of Table 2 below. After dissolving completely at 80 ° C., the solution was sterilized at 95 ° C. for 30 minutes, sealed, and cooled for 18 hours.

표2 실시예 2에 따른 항산화 음료의 조성표Table 2 Composition table of antioxidant drink according to Example 2

방냉시킨 용액을 10μ마이크로 필터로 수회 반복 여과하여 다갈색의 맑은 액상을 얻은 후 정량씩 충진 밀봉하였다. 이 액상을 95∼100℃에서 30분간 후살균하고 포장하여 본 제품의 완제품을 제조하였다.The cooled solution was repeatedly filtered several times with a 10 占 micro filter to obtain a dark brown clear liquid, which was filled and sealed by quantitation. The liquid was then sterilized and packaged at 95 to 100 ° C. for 30 minutes to prepare a finished product of this product.

실시예 3Example 3

실시예 1에서 제조된 저분자화된 홍삼 사포닌에 GMT-SOD를 제거한 것을 제외하고는실시예 2와 동일한 성분과 조성비로 혼합하고 동일한 방법으로 글루메이트가 제거된 홍삼 사포닌 음료를 제조하였다.Except that GMT-SOD was removed from the low molecular weight red ginseng saponin prepared in Example 1, red ginseng saponin was prepared by mixing the same components and compositions as in Example 2 and removing the glutate in the same manner.

본 발명의 실시예에 따라 제조된 저분자화된 홍삼 사포닌과 글루메이트를 포함한 음료에 대하여 관능검사 및 식품공전규격 검사방법에 따라 안정성 시험을 실시하였다. 시험 방법은 포장제품을 기준으로 하여 전기 항온기(40℃)에서 60일간 보관중인 제품의 색상, 풍미, 이미, 이취를 변화에 따른 관능검사원 5명이 검사하여 성상을 5점 대비표 중 3.0이상이면 품질변화가 거의 없는 제품으로 소비자에게 만족도를 줄 수 있고 상품성이 있는 제품으로 식품공전의 규격대로 검사하여 그 결과를 아래 표3에 나타내었다.Stability test was performed according to the sensory test and food standards test method for a beverage containing low molecular weight red ginseng saponin and glutate prepared according to an embodiment of the present invention. The test method is based on the packaged product and five sensory inspectors inspecting the color, flavor, and odor of the product stored in an electric thermostat (40 ℃) for 60 days. It is a product with little change, which can give consumers satisfaction, and it is a product with merchandise, and the result is shown in Table 3 below.

표3Table 3

표3의 검사결과 본 발명의 실시예에 따라 제조된 음료는 18개월 이상 성상이나 일반세균 및 대장균에 대하여 모두 그 안정성이 입증되었다.As a result of the test of Table 3, the beverage prepared according to the embodiment of the present invention has been proved its stability against the appearance and general bacteria and E. coli over 18 months.

본 발명의 실시예에 따라 제조된 음료에 대하여 항산화능, 즉 자유 라디칼 소거능을 다음과 같이 측정하였다. 사용된 방법은 1,1-Diphenyl-2-Pycryl-Hydrazyl(DPPH)방법으로 수행하였다. DPPH는 비교적 안정한 자유 라디칼로서 라디칼 상태로 존재시 517㎚에서 최대 흡광도를 나타내며 소거되면 흡광성을 잃는다. DPPH는 미국 시그마(Sigma)사의 것을 사용하였으며 에탄올 50㎖에 0.006g을 녹인 후 물 50㎖를 가하여 0.006%용액을 만들었다. 이 DPPH 용액을 3㎖를 취하여 시험관에 넣은 후 본 발명의 실시예 2에 따른 음료를 0.05㎖에서 0.55㎖까지 각 농도별로 취하여 잘 섞어 실온에서 15분간 방치한 후 517㎚에서의 흡광도를 측정하였다. 이때, 대조군으로는 본 발명에 따른 음료 대신 물을 넣은 것을 사용하였다. 시료의 흡광도와 대조군의 흡광도를 비교하여 도1에 나타내었다.Antioxidant activity, ie free radical scavenging activity, was measured as follows for the beverages prepared according to the embodiment of the present invention. The method used was performed by the 1,1-Diphenyl-2-Pycryl-Hydrazyl (DPPH) method. DPPH is a relatively stable free radical which, when present in the radical state, exhibits maximum absorbance at 517 nm and loses absorbance when erased. DPPH was used by Sigma, USA, and 0.006 g of 50 ml of ethanol was dissolved, and 50 ml of water was added to make a 0.006% solution. After taking 3 ml of this DPPH solution into a test tube, the beverage according to Example 2 of the present invention was taken from 0.05 ml to 0.55 ml for each concentration, mixed well, and left at room temperature for 15 minutes, and the absorbance at 517 nm was measured. At this time, the control was used to put water instead of the beverage according to the present invention. The absorbance of the sample is compared with that of the control group and is shown in FIG. 1.

도1에서 본 발명에 따른 음료의 자유 라디칼 소거능 즉, 항산화능을 나타내었다. 자유 라디칼 소거능은 과산화 지질산화의 연쇄 반응에 관여하는 산화성 자유 라디칼에 전자를 제공하여 연쇄 반응을 정지시켜 산화를 억제하므로 항산화능의 척도가 된다. 따라서, 도1에서 알 수 있듯이, 본 발명에 따른 홍삼 사포닌에 글루메이트를 첨가한 음료의 자유 라디칼 소거능을 측정한 결과 시료를 넣지 않은 대조군에 비하여 적은 양에서도 2.5배 내지 3.0배 우수한 항산화능을 나타냄을 알 수 있다.1 shows free radical scavenging ability, that is, antioxidant capacity, of the beverage according to the present invention. The free radical scavenging ability provides an electron to the oxidative free radicals involved in the chain reaction of lipid peroxide, thereby stopping the chain reaction and inhibiting oxidation, thus becoming a measure of antioxidant capacity. Therefore, as can be seen in Figure 1, the free radical scavenging ability of the beverage added glutamate to red ginseng saponin according to the present invention showed a 2.5 to 3.0 times better antioxidant capacity than a control without a sample It can be seen.

본 발명의 실시예에 따른 음료에 대한 항산화능에 있어서 글루메이트의 역할을 알아보기 위하여 홍삼 사포닌과 글루메이트를 포함한 실시예 2에서 제조된 음료와 글루메이트를 제거한 실시예 3에서 제조된 시료에 대하여 아래와 같은 실험을 실시하였다. 본 발명에 따른 음료를 시료로 0.2㎖ 취하여 2% 탄산나트륨(Na2CO3) 2.0㎖를 넣어 2분간 잘 섞은 후 발색시약으로 Folin-ciocalpeu's reagent를 0.2㎖(50%) 넣어서 잘 섞어서 실온에 방치한 후 750㎚에서 흡광도를 측정하여 항산화 활성을 나타내는 성분인 토탈 페놀산(total phenolic acid)의 양을 계산하였다. 이때 시료는0.2㎖에서 17㎖까지 각 농도별로 취하였으며 표준시료(standard)로 chlorogenic acid를 사용하였다. 대조군으로 실시예 3에서 제조된 시료를 동일한 농도별로 취하여 흡광도를 측정하여 시료를 측정한 값과 비교하여 그 결과를 도2에 나타내었다.In order to determine the role of glutmate in the antioxidant capacity of the beverage according to an embodiment of the present invention for the sample prepared in Example 3, in which the beverage and glutate prepared in Example 2 including red ginseng saponin and glutate were removed, The same experiment was conducted. Take 0.2 ml of the beverage according to the present invention as a sample, add 2.0 ml of 2% sodium carbonate (Na 2 CO 3 ), mix well for 2 minutes, add 0.2 ml (50%) of Folin-ciocalpeu's reagent as a color development reagent, and leave it at room temperature. After measuring the absorbance at 750nm to calculate the amount of total phenolic acid (total phenolic acid) that is a component showing antioxidant activity. At this time, samples were taken at each concentration from 0.2ml to 17ml and chlorogenic acid was used as a standard sample. As a control, the samples prepared in Example 3 were taken at the same concentration, and the absorbance was measured. The results are shown in FIG.

도2에서 본 발명에 따른 음료의 항산화능에 있어서 글루메이트의 역할을 나타낸 것으로 본 발명에 따른 음료와 글루메이트를 제거한 음료에 대해서 항산화능을 나타내는 성분인 토탈 페놀산의 양을 측정하였다. 도2에서 알 수 있듯이, 본 발명에 따른 음료는 토탈 페놀산의 양이 16.94㎎/㎖인 반면 SOD가 제거된 시료의 토탈 페놀산의 양은 1.99㎎/㎖를 나타내어 항산화능에 있어서 홍삼 사포닌 뿐 아니라 글루메이트의 역할 또한 중요함을 알 수 있다. 즉, 본 발명에서는 홍삼 사포닌과 글루메이트를 포함하여 우수한 항산화능을 나타내는 음료를 개발하였다.Figure 2 shows the role of glutmate in the antioxidant capacity of the beverage according to the present invention was measured for the amount of total phenolic acid which is a component showing the antioxidant activity for the beverage and the beverage without glutamate according to the present invention. As can be seen in Figure 2, the beverage according to the present invention is a total phenolic acid amount of 16.94 mg / ㎖ while the total amount of phenolic acid of the SOD-removed sample shows 1.99 mg / ㎖ not only red ginseng saponin in antioxidant capacity The role of the mate is also important. That is, the present invention has developed a beverage that exhibits excellent antioxidant capacity, including red ginseng saponin and glutate.

본 발명에 따른 항산화 음료는 홍삼 사포닌을 효소 처리하여 저분자화하여 항산화능이 향상된 홍삼 사포닌과 항산화 물질인 글루메이트를 포함하여 제조함으로써 우수한 자유 라디칼 소거능을 나타내어 자유 라디칼 생성이 주요 원인인 항암요법에 의한 부작용을 억제하는 효과가 크며 자유 라디칼에 의해 발생하는 여러 가지 질병을 방지하는 효과가 있다. 나아가 본 발명에 따른 항산화 음료를 지속적으로 음용함으로써 전체적인 면역력을 증강시킬 수 있는 효과가 있다.Antioxidant beverages according to the present invention are prepared by including red ginseng saponin with improved antioxidant capacity and red ginseng saponin and glutamate, which is an antioxidant substance, to show excellent free radical scavenging ability. It is effective in inhibiting the effects of various diseases caused by free radicals. Furthermore, by continuously drinking the antioxidant drink according to the present invention there is an effect that can enhance the overall immunity.

이상에서 본 발명은 기재된 구체예에서만 상세히 설명되었지만 본 발명의 기술사상 범위 내에서 다양한 변형 및 수정이 가능함은 당업자에게 있어서 명백한 것이다.Although the present invention has been described in detail only in the described embodiments, it will be apparent to those skilled in the art that various modifications and variations are possible within the technical spirit of the present invention.

Claims (3)

저분자화된 홍삼 사포닌과 활성산소 억제 효과를 갖는 글루메이트를 포함하는 항암요법에 따른 부작용 억제 효과를 갖는 항산화 음료.An antioxidant beverage having a side effect inhibitory effect according to an anticancer therapy comprising low molecular weight red ginseng saponin and a glutate having an active oxygen inhibitory effect. 제 1항에 있어서,The method of claim 1, 상기 저분자화된 홍삼 사포닌은 1 내지 15 중량%, 글루메이트는 1 내지 6 중량%를 함유하는 것을 특징으로 하는 상기 항암요법에 따른 부작용 억제 효과를 갖는 항산화 음료.The low molecular weight red ginseng saponin is 1 to 15% by weight, glutamate containing 1 to 6% by weight of the antioxidant drink having a side effect inhibitory effect according to the anticancer therapy. 홍삼의 사포닌을 효소 처리하여 저분자화하는 단계;Low molecular weight by enzyme treatment of saponin of red ginseng; 상기 저분자화된 사포닌 1 내지 15 중량%에 활성산소 억제 효과를 갖는 글루메이트 1내지 5 중량%, 항산화 기능성을 향상시키는 보조성분 및 향이나 맛을 가미하는 보조제를 혼합하여 정제수에 완전 용해시키는 단계; 및1 to 5% by weight of the low molecular weight saponin, glutamate 1 to 5% by weight of the active oxygen inhibitory effect, an auxiliary component to improve the antioxidant function and aroma or flavoring adjuvant is completely dissolved in purified water; And 상기 혼합용액을 살균 밀봉하여 방냉하고 반복 여과 처리하는 단계;Sterilizing and sealing the mixed solution to cool and repeat filtration; 를 포함하는 항암요법에 따른 부작용 억제 효과를 갖는 항산화 음료의 제조방법.Method for producing an antioxidant beverage having a side effect inhibitory effect according to the anticancer therapy.
KR1020010024720A 2001-05-07 2001-05-07 Antioxidative drink excellent in inhibiting the side effects according to anticancer therapy and the method of manufacturing the same KR100355012B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
KR1020010024720A KR100355012B1 (en) 2001-05-07 2001-05-07 Antioxidative drink excellent in inhibiting the side effects according to anticancer therapy and the method of manufacturing the same
JP2002132067A JP2002348245A (en) 2001-05-07 2002-05-07 Method for changing effective ingredients of ginseng radix rubra into low molecular weight compounds, and method for preparing antioxidizing drink

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020010024720A KR100355012B1 (en) 2001-05-07 2001-05-07 Antioxidative drink excellent in inhibiting the side effects according to anticancer therapy and the method of manufacturing the same

Publications (2)

Publication Number Publication Date
KR20020040532A true KR20020040532A (en) 2002-05-30
KR100355012B1 KR100355012B1 (en) 2002-10-11

Family

ID=19709142

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020010024720A KR100355012B1 (en) 2001-05-07 2001-05-07 Antioxidative drink excellent in inhibiting the side effects according to anticancer therapy and the method of manufacturing the same

Country Status (1)

Country Link
KR (1) KR100355012B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100543665B1 (en) * 2002-10-21 2006-01-20 정혜경 Method for producing beer containing antioxidants

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100472098B1 (en) * 2002-11-15 2005-03-11 김항종 Manufacturing method of health drink using black ginseng and black rice

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100543665B1 (en) * 2002-10-21 2006-01-20 정혜경 Method for producing beer containing antioxidants

Also Published As

Publication number Publication date
KR100355012B1 (en) 2002-10-11

Similar Documents

Publication Publication Date Title
Murcia et al. Evaluation of the antioxidant properties of Mediterranean and tropical fruits compared with common food additives
KR101682552B1 (en) Antioxidant composition comprising red ginseng extracts and berrylike mixtures
WO2006090935A1 (en) Acerola fruit-derived pectin and use thereof
KR101936294B1 (en) Composition comprising for skin-whitening and anti-wrinkling extract of Rumex acetosella L. or extract of Hydrangea serrata
KR102105111B1 (en) Energy drink composition containing increased biological active materials and preparation method thereof
Vinayagam et al. Antioxidant activity of methanolic extracts of leaves and flowers of Nerium indicum
CN109200045A (en) Application and pharmaceutical composition of the Anthocyanin-rich Extract in the pharmaceutical composition of preparation prevention and treatment anthracene nucleus medicament myocardiocyte toxicity
CN106665891A (en) Preparation and use method of snow chrysanthemum polyphenol
KR102298042B1 (en) Composition for antioxidant and anti-inflammatory comprising extract of pepper seeds
Conde et al. Extraction of natural antioxidants from plant foods
Ko et al. Antioxidant and antiradical activities of Wu Ling Shen in a cell free system
KR20200145897A (en) Method for producing extracts of sweet potato with enhanced antioxidative activity and extracts of sweet potato produced by the same method
KR101142370B1 (en) Method for producing fermented solution of mushroom with enhanced antioxidative activity and fermented solution of mushroom produced by the same
Guo et al. Antioxidant and antidiabetic activities of Ulmus davidiana extracts
Li et al. Investigation the nutritional properties of Auricularia auricula pulp fermented with Lactobacillus strains and their effects on gut microbiota
KR100760263B1 (en) Manufacturing method of beverage composition comprising purple-fleshed sweet potato
KR100355012B1 (en) Antioxidative drink excellent in inhibiting the side effects according to anticancer therapy and the method of manufacturing the same
CN109549036A (en) A kind of composite juice and preparation method thereof of collaboration fructus lycii effect
KR101546436B1 (en) The mugwort extracts and method for manufacturing thereof
Omoregie et al. In vitro antioxidant activity and the effect of methanolic extracts of some local plants on nutritionally stressed rats
JP2002348245A (en) Method for changing effective ingredients of ginseng radix rubra into low molecular weight compounds, and method for preparing antioxidizing drink
KR102283497B1 (en) Stick jelly with the effect of antioxidation
Marnewick Antioxidant Properties of Rooibos (Aspalathus linearis)—In Vitro and in Vivo Evidence
CN105188419B (en) The method for preparing muscat pomace extract
KR101435872B1 (en) Cosmetic composition for anti-oxidation and anti-aging comprising Ginseng seeds extract

Legal Events

Date Code Title Description
A201 Request for examination
N231 Notification of change of applicant
G15R Request for early publication
A302 Request for accelerated examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20110916

Year of fee payment: 10

LAPS Lapse due to unpaid annual fee